The ophthalmic drugs contract manufacturing market

  • Blog Title
    Blog posted on : 03-12-2021

    The ophthalmic drugs contract manufacturing market

    Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

     

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030.”

     

    The report features an extensive study of the contract services market for ophthalmic products and solutions. It features in-depth analyses, highlighting the capabilities of a diverse set of CMOs and CDMOs. Amongst other elements, the report includes:

    • A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240 CMOs and analysis based on a number of relevant parameters.
    • A competitiveness analysis of prominent contract manufacturers, featuring insightful pictorial summaries and representations.
    • Elaborate profiles of key players that offer a diverse range of capabilities for the contract development, manufacturing and packaging of ophthalmic drug products.
    • A detailed clinical trial analysis of completed, ongoing and planned studies of various ophthalmic drug products.
    • An estimate of the overall, annual capacity for manufacturing ophthalmic APIs and drug FDFs based on data reported by industry stakeholders in the public domain.
    • An informed estimate of the annual clinical and commercial demand for ophthalmic APIs and drug FDFs.
    • A discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, including a Harvey ball analysis highlighting the relative effect of each SWOT parameter on the overall industry.
    • A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract manufacturing services to ophthalmic drug developers.
    • A discussion on the emerging trends and potential market drivers, which are likely to impact the evolution of the market in the coming years.
    • A detailed list of over 55 ophthalmic medical device contract manufacturers, along with information on a number of relevant parameters.

     

    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

    • Type of product
    • Ophthalmic API
    • Ophthalmic drug FDF

     

    To request a sample copy / brochure, please visit this - https://www.rootsanalysis.com/reports/294/request-sample.html

     

    • Type of FDF manufactured
    • Solid
    • Semi-solid
    • Liquid / suspension

     

    • Type of primary packaging
    • Ampoule / vial 
    • Glass / plastic bottle
    • Ointment tube
    • Blister packing
    • Other forms

     

    • Scale of manufacturing
    • Clinical
    • Commercial

     

    • Company size
    • Small
    • Mid-sized
    • Large
    • Very large

     

    • Target disease indication
    • Age-related macular degeneration
    • Dry eye
    • Glaucoma
    • Other disease segments

     

    • Key geographical regions
    • North America (US, Canada and Mexico)
    • Europe (UK, Germany, France, Spain, Italy and rest of Europe)
    • Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)
    • Rest of the world

     

    Key companies covered in the report

    • Akorn
    • Akums
    • Bal Pharma
    • Catalent
    • Cayman Chemical
    • Entod Pharmaceuticals
    • Farmigea
    • Glenmark Pharmaceuticals
    • Indiana Ophthalmics
    • Lomapharm
    • Medichem
    • Pillar5 Pharma
    • Recipharm
    • Salvat
    • Sterling Pharmaceutical Services
    • Sunways India

     

    For more information please click on the following link:

    https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

     

    Other Recent Offerings

    1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
    2. Pharmaceutical Continuous Manufacturing Market, 2020-2030
    3. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

     

     

     

    Contact Details 

    Ben Johnson 

    +1 (415) 800 3415 

    ben.johnson@rootsanalysis.com 

     
     

    Roots Analysis 

    Web: https://www.rootsanalysis.com/ 

    LinkedIn: https://in.linkedin.com/company/roots-analysis 

    Twitter: https://twitter.com/RootsAnalysis.com 

    Medium: https://medium.com/@RootsAnalysis 

    Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ 

    Quora: https://rootsanalysisinsights.quora.com/